Vaccine News and Research

Latest Vaccine News and Research

New technique protects promising TB vaccine from heat damage

Scientists working on a new tuberculosis vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.

8 Aug 2019

Federal experts’ advice on HPV vaccine could leave adults confused

Vaccination decisions are usually pretty straightforward. People either meet the criteria for the vaccine based on their age or other factors or they don't. But when a federal panel recently recommended an update to the human papillomavirus (HPV) vaccine guidelines, it left a lot of uncertainty.

8 Aug 2019

Exposure to C. Difficile in infancy produces immunity against gastrointestinal infection

Exposure to C. difficile in infancy produces an immune response that might protect against this gastrointestinal infection later in childhood, according to a study published in Clinical Infectious Diseases journal

7 Aug 2019

Blocking key mineral uptake could prevent gonorrhea infection

A team of researchers may have found a way to block gonorrhea infection by blocking bacterial pathogen from using zinc, an essential mineral found in many food sources.

6 Aug 2019

Major step toward creation of vaccine that could neutralize ‘superbug’

Researchers from the Los Angeles Biomedical Research Institute have taken a major step toward the creation of vaccine that could neutralize the culprit behind a growing public health crisis.

6 Aug 2019

New nanovaccine for deadly skin cancer

Tel Aviv scientists have published their version of a vaccine against the deadly skin cancer malignant melanoma, which arises from the pigment producing cells of the skin. This is the most feared form of skin cancer, with a high tendency to metastasize to distant parts of the body, including the brain.

6 Aug 2019

New research explains why some cancers don't respond to immunotherapy

New research has uncovered a mechanism thought to explain why some cancers don't respond to a widely used form of immunotherapy called "checkpoint inhibitors" or anti-PD-1.

6 Aug 2019

Tel Aviv researchers develop a nano-vaccine for the most aggressive skin cancer

Researchers at Tel Aviv University have developed a novel nano-vaccine for melanoma, the most aggressive type of skin cancer.

5 Aug 2019

Primary DENV or ZIKV infection has no effect on course of secondary infection in macaques

Previous infection with either Zika virus or dengue virus has no apparent effect on the clinical course of subsequent infection with the other virus, according to a study published August 1 in the open-access journal PLOS Pathogens by David O'Connor of the University of Wisconsin-Madison, and colleagues.

5 Aug 2019

New tool makes it easier to study how influenza viruses cause disease

Studying how influenza viruses cause disease just got a little easier, thanks to a new tool developed at South Dakota State University.

3 Aug 2019

Study finds fewer deaths among elderly intensive care patients vaccinated against influenza

It appears that an influenza vaccine does not just work when it comes to influenza. A new study shows that elderly people who have been admitted to an intensive care units have less risk of dying and of suffering a blood clot or bleeding in the brain if they have been vaccinated.

2 Aug 2019

New drug combination successfully reduces levels of bovine leukemia virus

Scientists have succeeded in reducing levels of the bovine leukemia virus in cows with severe infections by combining an immune checkpoint inhibitor and an enzyme inhibitor.

2 Aug 2019

Combination of vaccine and medicated cream can reduce recurrence of genital herpes

Yale investigators have shown that the combination of a vaccine and a medicated cream is a promising strategy to dramatically reduce the recurrence of genital herpes.

2 Aug 2019

Congo’s Ebola outbreak continues rampant

It was a year ago that the Ebola virus outbreak in the Congo became official. And far from subsiding, just two weeks ago it became “a public health emergency of international concern”. More than 2,600 cases have been confirmed and over 1,800 deaths in the affected provinces of the Democratic Republic of the Congo. A third of these are children.

1 Aug 2019

Scientists discover lung cell that can hustle to repair its damaged DNA and survive influenza

Scientists at Duke University have identified one kind of lung cell that can hustle to repair its damaged DNA and survive an attack of the influenza A virus while other kinds of cells around it die in droves.

30 Jul 2019

Researchers discover SIGN-R1 molecule that recognizes multiple variants of influenza

A team of researchers from the Institute for Research in Biomedicine (IRB, affiliated to USI Università della Svizzera italiana, Switzerland) have discovered and identified a molecule - SIGN-R1 - capable of recognizing the multiple variants of influenza and consequently 'directing' the immune response in individuals affected by the disease.

30 Jul 2019

New gene-editing study finds protective genes against Zika virus

Tel Aviv scientists have discovered certain genes that protect the host organism against attack by Zika virus, raising hopes of an eventual vaccine or cure for this dreaded viral disease.

28 Jul 2019

Challenging the Glo-Germ Technique for Aerosol Containment During Cell Sorting

Researchers have developed a robust alternative to the glo-germ assay to determine cell sorter aerosol containment that is rapid, accurate and efficient.

25 Jul 2019

New vaccine shows promise against toughest HIV strains

A new study reports successful immunization against a so-far invincible “death star” strain of an HIV-related laboratory virus (SIVmac239) and another tough strain. The new approach also achieves long-term protection with a single dose, showing that gene therapy could allow broad and durable protection, based on a modified form of the CD4 protein that allows HIV entry into human cells.

24 Jul 2019

One dose of HPV vaccine has comparable effectiveness to two or three doses

One dose of human papillomavirus (HPV) vaccine has comparable effectiveness to two or three doses for preventing cervical pre-cancer, according to a new study.

24 Jul 2019